Citadel Advisors’s FTAC Hera Acquisition Corp. Class A Ordinary Shares HERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-625,000
Closed -$6.33M 16071
2022
Q4
$6.33M Sell
625,000
-2,381
-0.4% -$23.8K ﹤0.01% 3492
2022
Q3
$6.23M Sell
627,381
-1,754,143
-74% -$17.3M ﹤0.01% 3523
2022
Q2
$23.3M Sell
2,381,524
-1,339,441
-36% -$13.1M 0.01% 1684
2022
Q1
$36.4M Buy
3,720,965
+1,173
+0% +$11.4K 0.01% 1367
2021
Q4
$36.3M Buy
3,719,792
+1,214,870
+48% +$11.9M 0.01% 1439
2021
Q3
$24.4M Buy
2,504,922
+3,918
+0.2% +$38.2K 0.01% 1786
2021
Q2
$24.4M Buy
+2,501,004
New +$24.4M 0.01% 1843

Citadel Advisors's HERA Position: Q1 2023 in Review

Citadel Advisors sold out of FTAC Hera Acquisition Corp. Class A Ordinary Shares (HERA) in Q1 2023, closing a stake of 625,000 shares — an estimated $6.33M sold.

Citadel Advisors first reported a position in HERA in Q2 2021 and held it in 7 quarters. The position peaked at $36.4M in Q1 2022. 0 funds tracked by Wall St. Rank hold HERA as of Q1 2023.

  • Citadel Advisors reported no remaining FTAC Hera Acquisition Corp. Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 625,000 FTAC Hera Acquisition Corp. Class A Ordinary Shares shares in Q1 2023, an estimated $6.33M.
  • Citadel Advisors first reported a position in FTAC Hera Acquisition Corp. Class A Ordinary Shares in Q2 2021 and held it in 7 quarters.
  • Citadel Advisors's FTAC Hera Acquisition Corp. Class A Ordinary Shares position peaked at $36.4M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held FTAC Hera Acquisition Corp. Class A Ordinary Shares as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.